Nature Technology Corporation (NTC) is a technology-based biologics development company, providing vector design and construction, process development and manufacturing (OEM) assistance to biotech and bio-pharmaceutical companies. NTC’s mission is to provide essential platform technology and services for the construction, delivery, and expression of new age biologics, including DNA vaccines, gene therapeutics, recombinant proteins. NTC is dedicated to innovating, developing and providing cost-effective, generic solutions for safe, efficient human therapy using viral as well as non-viral systems for gene delivery.
This privately owned company is currently located in The University of Nebraska Technology Park in Lincoln, Nebraska, USA. NTC has acquired exclusive world rights to six issued US Patents (retrotransposon gene delivery platform technology), with additional US and international patents pending.
NTC is the leading manufacturer and supplier of highly purified, endotoxin-free DNA molecules and
recombinant proteins.
|
|
